These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 7910974)
1. Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness. Ganguli R; Yang Z; Shurin G; Chengappa KN; Brar JS; Gubbi AV; Rabin BS Psychiatry Res; 1994 Jan; 51(1):1-10. PubMed ID: 7910974 [TBL] [Abstract][Full Text] [Related]
2. Serum levels of interleukin-6 and tumor necrosis factor-alpha in exacerbation and remission phase of schizophrenia. Dunjic-Kostic B; Jasovic-Gasic M; Ivkovic M; Radonjic NV; Pantovic M; Damjanovic A; Poznanovic ST; Jovanovic A; Nikolic T; Petronijevic ND Psychiatr Danub; 2013 Mar; 25(1):55-61. PubMed ID: 23470607 [TBL] [Abstract][Full Text] [Related]
3. Altered serum levels of interleukin-3 in first-episode drug-naive and chronic medicated schizophrenia. Fu YY; Zhang T; Xiu MH; Tang W; Han M; Yun LT; Chen DC; Chen S; Tan SP; Soares JC; Tang WJ; Zhang XY Schizophr Res; 2016 Oct; 176(2-3):196-200. PubMed ID: 27237600 [TBL] [Abstract][Full Text] [Related]
4. Decreased serum levels of interleukin-2 and interleukin-6 in Indian Bengalee schizophrenic patients. Singh B; Bera NK; Nayak CR; Chaudhuri TK Cytokine; 2009 Jul; 47(1):1-5. PubMed ID: 19502081 [TBL] [Abstract][Full Text] [Related]
5. Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment. Erbağci AB; Herken H; Köylüoglu O; Yilmaz N; Tarakçioglu M Mediators Inflamm; 2001 Jun; 10(3):109-15. PubMed ID: 11545247 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Frommberger UH; Bauer J; Haselbauer P; Fräulin A; Riemann D; Berger M Eur Arch Psychiatry Clin Neurosci; 1997; 247(4):228-33. PubMed ID: 9332905 [TBL] [Abstract][Full Text] [Related]
7. Elevated interleukin-18 serum levels in chronic schizophrenia: Association with psychopathology. Xiu MH; Chen DC; Wang D; Zhang K; Dong A; Tang W; Zhang F; Liu LJ; Liu JH; Liu HB; Yang FD; Kosten TR; Zhang XY J Psychiatr Res; 2012 Aug; 46(8):1093-8. PubMed ID: 22647522 [TBL] [Abstract][Full Text] [Related]
8. Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology. Zhang XY; Zhou DF; Zhang PY; Wu GY; Cao LY; Shen YC Schizophr Res; 2002 Oct; 57(2-3):247-58. PubMed ID: 12223256 [TBL] [Abstract][Full Text] [Related]
9. Antipsychotic treatment may alter T-helper (TH) 2 arm cytokines. Pae CU; Yoon CH; Kim TS; Kim JJ; Park SH; Lee CU; Lee SJ; Lee C; Paik IH Int Immunopharmacol; 2006 Apr; 6(4):666-71. PubMed ID: 16504930 [TBL] [Abstract][Full Text] [Related]
10. Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders. Igue R; Potvin S; Bah R; Stip E; Bouchard RH; Lipp O; Gendron A; Kouassi E Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1695-8. PubMed ID: 21627977 [TBL] [Abstract][Full Text] [Related]
11. Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients. Theodoropoulou S; Spanakos G; Baxevanis CN; Economou M; Gritzapis AD; Papamichail MP; Stefanis CN Schizophr Res; 2001 Jan; 47(1):13-25. PubMed ID: 11163541 [TBL] [Abstract][Full Text] [Related]
12. [Analysis of the changes of serum high mobility group protein B1 and cytokines in first-episode schizophrenia patients]. Zhu Q; Li X; Hie G; Yuan X; Lü L; Song X Zhonghua Yi Xue Za Zhi; 2015 Dec; 95(47):3818-22. PubMed ID: 27337797 [TBL] [Abstract][Full Text] [Related]
13. Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics. Zhang XY; Zhou DF; Cao LY; Wu GY; Shen YC Neuropsychopharmacology; 2005 Aug; 30(8):1532-8. PubMed ID: 15886721 [TBL] [Abstract][Full Text] [Related]
14. Serum levels of interleukin 6 in schizophrenic patients during treatment augmentation with sarcosine (results of the PULSAR study). Strzelecki D; Urban-Kowalczyk M; Wysokiński A Hum Psychopharmacol; 2018 Mar; 33(2):e2652. PubMed ID: 29417623 [TBL] [Abstract][Full Text] [Related]
15. Plasma and cerebrospinal fluid interleukin-1 beta and interleukin-6 in hospitalized schizophrenic patients. Katila H; Hurme M; Wahlbeck K; Appelberg B; Rimón R Neuropsychobiology; 1994; 30(1):20-3. PubMed ID: 7969854 [TBL] [Abstract][Full Text] [Related]
16. Increased interleukin-6 and tumor necrosis factor alpha in first episode schizophrenia patients versus healthy controls. Kubistova A; Horacek J; Novak T Psychiatr Danub; 2012 Sep; 24 Suppl 1():S153-6. PubMed ID: 22945211 [TBL] [Abstract][Full Text] [Related]
17. [Effect of clozapine and risperidone on serum cytokine levels in patients with first-episode paranoid schizophrenia]. Lü LX; Guo SQ; Chen W; Li Q; Cheng J; Guo JH Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1251-4. PubMed ID: 15567770 [TBL] [Abstract][Full Text] [Related]
18. The association of cognitive performance and IL-6 levels in schizophrenia is influenced by age and antipsychotic treatment. Ribeiro-Santos R; de Campos-Carli SM; Ferretjans R; Teixeira-Carvalho A; Martins-Filho OA; Teixeira AL; Salgado JV Nord J Psychiatry; 2020 Apr; 74(3):187-193. PubMed ID: 31738648 [No Abstract] [Full Text] [Related]
19. Elevated levels of C-reactive protein and IL-6 among the antipsychotic medicating schizophrenia patients of Siliguri, West Bengal, India. Gurung J; Chamlagai D; Bera NK; Chaudhuri TK; Singh B Nord J Psychiatry; 2018 May; 72(4):311-317. PubMed ID: 29464976 [TBL] [Abstract][Full Text] [Related]
20. Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics. Maes M; Bocchio Chiavetto L; Bignotti S; Battisa Tura G; Pioli R; Boin F; Kenis G; Bosmans E; de Jongh R; Lin A; Racagni G; Altamura CA Eur Neuropsychopharmacol; 2000 Mar; 10(2):119-24. PubMed ID: 10706993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]